Background: Lipopolysaccharide (LPS) is known to activate macrophages, causing the release of toxic cytokines that may provoke inflammation and shock. One of the most important and best studied of these cytokines is tumor necrosis factor (TNF). Details of the signaling pathway leading to TNF biosynthesis remain unclear. The pathway is branched in the sense that TNF gene transcription and TNF mRNA translation are
INTRODUCTION
Bacterial endotoxin (lipopolysaccharide; LPS) is believed to elicit most of its untoward effects by provoking cytokine synthesis in cells of reticuloendothelial origin, e.g., macrophages (1) (2) (3) .
Tumor necrosis factor (TNF) is believed to be one of the most important of these cytokine mediators. Within 2 hr following LPS stimulation, TNF is elaborated as one of the major secretory products of macrophages (4, 5) . Passive immunization against TNF offers strong protection against the lethal effect of LPS (6) , and direct administration of TNF causes shock and tissue injury (7) .
For these reasons, the signal transduction pathway utilized by LPS, leading to the synthesis and release of TNF, assumes considerable importance. Moreover, responses of the TNF gene are an excellent endpoint for studies of LPS signaling in macrophages since the rate of TNF biosynthesis increases 1,000-fold or more following stimulation by LPS (8) . Previous work has established that LPS is concentrated through the formation of complexes with lipopolysaccharide binding protein (LBP) and then engages CD14, a GPIlinked plasma membrane protein (9, 10) . As CD 14 has no obvious means of generating signals within the cytoplasmic compartment, the initial triggering mechanism for LPS signaling remains obscure.
It is recognized that the LPS signal traverses a biological "bottleneck" in the sense that it is minimally dependent upon the product of a single gene, known as the Lps gene (11) (12) (13) . It is widely assumed that this gene, defective in LPS-unresponsive C3H/HeJ and C57B 1OSnCr mice, encodes an early component of the signal transduction apparatus. Once a signal has been initiated, the activation pathway bifurcates, ultimately yielding both transcriptional and translational activation of TNF biosynthesis (8) . Tran- scriptional activation of TNF synthesis is minimally dependent upon NF-KB translocation, insofar as deletion of the NF-KB motifs present in the TNF promoter/enhancer region is sufficient to abolish LPS responsiveness (14) . Translational activation depends upon defeat of translational repression imposed by the UA-rich element present in the 3'-UTR of the mRNA encoding TNF and several other cytokines (15, 16) .
TNF biosynthesis can be blocked by glucocorticoid agonists, which impede both transcriptional and translational activation pathways (8) , by cAMP analogs or phosphodiesterase inhibitors, which selectively block the transcriptional response (17) , and by pyridinyl imidazole derivatives, which selectively block the translational response (18) . The molecular targets of each inhibitor remain to be determined; however, these data lend credence to the view that the signaling pathway bifurcates into transcriptional and translational components.
Certain aspects of the LPS signaling pathway appear to be unique to macrophages. Notably, when an immortalized mouse macrophage line (RAW 264.7) is fused with an immortalized fibroblast line (NIH 3T3) the resulting hybrid cells are endotoxin unresponsive (19) . Presumably, essential component(s) of the LPS signal transduction pathway, like the TNF gene itself (19) , are extinguished following fusion.
Although little is known about the biochemical signaling pathway responsible for transmitting signals generated by LPS to the nucleus, recent studies have suggested that it may be initiated by a tyrosine kinase (20) (21) (22) . Thus, LPS induces tyrosine phosphorylation in monocytic cell lines and this response can be blocked by tyrosine kinase inhibitors (20, 21) . Moreover, several functional consequences of LPS exposure can be inhibited by tyrosine kinase inhibitors (20, 22) .
A number of tyrosine kinase initiated pathways activate a cascade of signaling molecules termed the mitogen-activated protein (MAP) kinase pathway (23, 24) . Activation of the tyrosine kinase by receptor ligation leads to autophosphorylation of the kinase and association with an adaptor protein such as Grb2 through the SH2 domain of the adaptor protein (25) . The adaptor protein is thought to bind to a guanine nucleotide exchange factor which in turn promotes the association of the proto-oncogene ras with GTP. GTP-bound ras binds to the proto-oncogene raf-I transporting it to the membrane where it is activated (26) (27) (28) . raf-1 is a serine threonine kinase that phosphorylates and activates a family of protein kinases termed MAP kinase or extracellular signal-regulated kinases (MEKs) (29) . MEKs phosphorylate MAP kinases on threonine and tyrosine residues increasing their catalytic activity 1,000-fold (30) (31) (32) . MAP kinases include extracellular signal regulated kinase (ERK) 1, ERK2, ERK3, ERK4, p54 MAP kinases (JNK or SAPs), and p57 MAP kinases (33) (34) (35) (36) (37) . One or more of these kinases are known to phosphorylate other protein kinases (e.g., Rsk, MAPKAP kinase 2), transcription factors (e.g., c-jun, myc, p62tcf/elk, tall, NF-IL6, and ATF-2) cytoskeletal proteins (microtubule-associated protein 2, tau), and a number of enzymes (phospholipase A2 and tyrosine hydroxylase) (38) . This pathway is thought to play an important role in cell growth and differentiation (39, 40) . In addition, recent evidence has demonstrated that some members of this pathway are required for T cells to produce IL-2 following antigen recognition (41, 42) .
Recent work has also suggested that LPS may trigger the activity of MAP kinases in monocytic and lymphocytic cell lines (21, (43) (44) (45) . Based on these findings, we considered that the MAP kinase pathway might transmit signals generated by LPS that are responsible for regulating TNF gene transcription and/or TNF mRNA translation. We therefore sought to investigate the role of the ras/raf-1/MEK/MAPK pathway in LPS-in-duced TNF production in macrophages. In order to do so, we studied the effect of LPS on the activity of the MAP kinase pathway in LPS-responsive and LPS-refractory cells. In addition, we sought to determine whether dominant inhibitory forms of ras and raf-1 blocked LPS-induced TNF promoter activity, and finally, whether an activated mutant of raf-1 stimulated LPS-induced TNF promoter activity.
MATERIALS AND METHODS
DNA Constructs raf-BXB and raf-C4B have been described previously (46, 47) . Both constructs were placed into a metallothionine-driven expression vector, pMEP (Invitrogen). pMEP contains the hygromycin resistance gene driven by the thymidine kinase promoter. A cDNA encoding a dominant inhibitory form of Ras (17N, 59T) was obtained from Dr. L. Feig (48) . The cDNA was inserted into the pCEP4 vector for use in these studies. A construct containing the cAMP regulated enhancer element (CRE) driving CAT (49) was obtained from Dr. Marc Montminy (Salk Institute, La Jolla, CA, U.S.A.). Constructs in which a TNF promoter drives the expression of CAT, in which a CMV promoter drives the expression of CAT, and in which a CAT coding sequence is followed by the TNF 3'-UTR were described previously (17, 50) . Reagents and Antibodies Phorbol myristate acetate (PMA; Sigma Chemical Co., St. Louis, MO, U.S.A.) was dissolved in ethanol and added to cells at a final concentration of 10 ng/ml. E. coli LPS, from strain 0127:B8, was obtained from Difco. The LPS was dissolved at a concentration of 1.0 mg/ml in sterile saline and frozen at -200C until use. It was added to cultured cells at the concentrations and for the length of time indicated in each figure. 8-bromocAMP (Sigma) was added to RAW 264.7 cells cultures at a concentration of 100 ,ug/ml for a period of 24 hr prior to harvest and CAT assay.
Rabbit polyclonal antisera raised to the ERK2 peptides A249 and 691, an antiserum raised to MEKi1 specific peptides A2227, and preimmune antiserum were generously provided by Dr. Melanie Cobb (51) . The production and biochemical characterization of recombinant histidine-tagged mutant K71->R human ERKI (rERKI) has been described previously (30 50 ,uM Na3VO4, 10 ,ug/ml of aprotinin, 1 mM leupeptin, 1 mM PMSF, and 5 mM benzamidine). The lysates were clarified by centrifugation (15,000 X g; 10 min), split into two equal fractions, and incubated with either 5 ,lI of A249, 5 ,l of preimmune sera, 10 Al A2227 (anti-MEK1 antiserum), or 10 ,l of control serum. Immune complexes were precipitated using SPA agarose. The immune complexes were washed once with RIPA-H buffer, once with 0.5 M LiCl, 100 mM Tris, pH 7.5, and once with 50 mM Tris, pH 7.6, 100 mM NaCl. The resulting pellets were incubated at 300C for 30 (Fig. 1 ) but in an atypical fashion. MEK1 and ERK2 activity were detectable 30 min after LPS was added to the cultures and activity peaked 60 min after stimulation. The response was independent of LPS-induced protein synthesis, however, as indicated by the fact that cycloheximide did not diminish kinase activation (data not shown). ERK2 induction was detected when LPS was added to the culture at concentrations as low as 10 ng/ml. Higher concentrations of LPS stimulated higher levels of ERK2 induction, and a maximal response was observed with the addition of LPS at a concentration of 1 jig/ml (Fig. 2) .
By contrast, ERK2 activity was not induced in RAW 264.7 X 3T3 hybrid cells which, as previously noted, fail to support LPS-induced TNF promoter responses (19) (Fig. 3) . The hybrid cells were, however, responsive to PMA induction; higher levels of ERK2 activity were induced by (Fig.  4) . The concentration of ERK2 in PMA-stimulated C3H/HeJ macrophages was comparable to that observed in C3H/HeN macrophages. 5 and 6A); at higher concentrations of LPS, cotransfection with the dominant negative ras construct did not block promoter activation. A dominant negative raf-1 inhibitor also consistently decreased the response to low concentrations of LPS (Figs. 5 and 6A) . As with the ras inhibitor, high concentrations of LPS were capable of stimulating the TNF promoter even in the presence of co-transfected raf-1 inhibitor. A deletion mutant of raf-1 lacking the regulatory domain (raf-BXB) has been found to be constitutively active in some cell types (46, 48) . This construct augmented the response of the reporter gene to all concentrations of LPS (Figs. Sand 6B).
In some experiments (Fig. 7) , a cAMP-responsive promoter was cotransfected with each of the two dominant-negative expression constructs and was still found responsive to induction by 8-bromo-cAMP. Moreover, the activity of the LPS-unresponsive CMV promoter was not influenced by cotransfection with either the ras or raf-1 inhibitors. Hence, the effect of the inhibitors was a specific one and appeared to impact Raf It has been suggested that LPS triggers changes in cellular physiology by activating a tyrosine kinase (20) (21) (22) 44) . The observation that a variety of tyrosine kinase-initiated signaling pathways activate ras, raf-1, MEKs, and ERKs is consistent with this conclusion. It is interesting to note, however, that in most of the previously described signal transduction pathways, the relevant upstream stimulus induces ERK activity within minutes. For example, ERK and MEKI activity peak 5 min after stimulation via the T cell receptor in T cells (56) . A similar rate of response is observed when NGF is applied to cells that express the NGF receptor (57) . The delayed response witnessed in macrophages exposed to LPS may suggest tardive activation of a certain upstream tyrosine kinase. Notably, however, ERK2 activity is stimulated in the presence of protein synthesis inhibitors (data not shown), indicating that stimulation of a pre-existing pathway, rather than the assembly of a new pathway through protein synthesis, occurs in the course of activation.
It is interesting to note that the inhibitory effect of dominant negative forms of raf-1 and ras on the transcriptional activity of the TNF promoter induced by LPS varies depending upon the concentration of LPS that is used. Thus, whereas the stimulatory effect of a low concentration of LPS is completely blocked, higher concentrations of LPS It is interesting to note that expression of the free catalytic domain of raf, which is constitutively active in a variety of cell types, is not sufficient to induce TNF promoter activity. There are several potential explanations for this finding. First, raf-BXB may be inactive in macrophages unless stimulated by LPS. We have observed a similar phenomenon in T cells, in which raf-BXB is not constitutively active, but is regulated by engagement of the T cell receptor for antigen (T. D. Geppert, unpublished data). Alternatively, the MAP kinase pathway may be necessary but not sufficient for TNF promoter activity. Thus, there may be a parallel pathway that does not involve raf-BXB that is required for TNF promoter activity. Whatever the explanation, the finding that raf-BXB activity promotes LPS-induced TNF promoter activity supports the hypothesis that raf-1 activity is required for LPSinduced TNF production.
Activated raf-I has recently been shown to phosphorylate IKB in a manner that allows NF-KB to separate from lKB and proceed to the nucleus (63) . raf-1 is also known to phosphorylate MEK1. As such, it may represent at least one of the physical branchpoints in the LPS signaling pathway, which, as noted above, resolves into both transcriptional and translational compo-nents. Viewed from this perspective, it seems likely that specific MAP kinase homolog(s) lie on the pathway leading to activation of the translational response.
